MedTrace Logo

Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone

NCT07226635 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-12-23

No results posted yet for this study

Summary

Drug: 2 single oral doses of midazolam, 2 single oral doses of prednisolone , and clofutriben once daily for 16 days.

Conditions

  • Healthy Participants

Interventions

DRUG

2 single oral doses of prednisolone

2 single oral doses of prednisolone

DRUG

midazolam

Drug: 2 single oral doses of midazolam ,

DRUG

clofutriben once daily for 16 days

clofutriben once daily for 16 days

Sponsors & Collaborators

  • Sparrow Pharmaceuticals

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-03
Primary Completion
2025-12-16
Completion
2025-12-16
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07226635 on ClinicalTrials.gov